Open Outbreak

Should I be worried about Filoviruses (Ebola and Marburg)?

Updated · Graded from official assessments; nothing here is medical advice.

Filoviruses (Ebola and Marburg) · Attention: high

If you are in the affected area high
WHO assessed the risk in the Democratic Republic of the Congo as “very high” on 14 August 2026, an assessment repeated in its 6 November bulletin. That bulletin says the assessment is being revised. According to WHO
If you are elsewhere in the same country or region high
WHO’s “very high” assessment applies to the Democratic Republic of the Congo nationally, not just its affected health zones. The assessment was made on 14 August 2026 and repeated on 6 November. According to WHO
If you are travelling there soon high
WHO’s 6 November bulletin repeats its 14 August assessment of high risk for countries sharing land borders with the Democratic Republic of the Congo. This is a geographic assessment, not a rating of your individual risk while travelling; WHO advises against general travel restrictions. According to WHO
If you are elsewhere in the world low
WHO assessed global risk as low on 14 August 2026 and repeated that assessment in its 6 November bulletin. WHO says the assessment is being revised. According to WHO

What is happening

Current filovirus activity is driven mainly by the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, concentrated in Ituri and North Kivu and documented in WHO notices since at least 8 October 2026. WHO’s 6 November bulletin reported official totals of 10,668 confirmed cases and 5,198 deaths through 3 November, with recent transmission in 51 health zones across eight affected provinces. A newer Arab News report published on 18 November attributed 11,376 confirmed cases and 5,568 deaths to WHO, but these remain media-relayed, unverified figures rather than independently verified official totals. WHO reported no new cases in Kenya or Nigeria in its latest bulletin, while Ethiopia declared its Marburg outbreak over on 26 January 2026. Officials are using isolation, laboratory testing, contact tracing, infection prevention, safe burials and cross-border surveillance, although insecurity and incomplete contact follow-up continue to hinder the response.

Who is affected and how it spreads

Ebola and Marburg viruses can cause severe disease in people and other primates. They spread mainly through direct contact with a sick person’s blood or other body fluids, contaminated objects, or exposure during unsafe care or burials. People providing care and those involved in burials can therefore be exposed; these viruses are not mainly spread through casual airborne contact in the way flu is. Vaccines and antibody treatments licensed for Zaire Ebola cannot be assumed effective or approved for Bundibugyo Ebola or Marburg.

What we are watching

Updates

Sources